- Investing Ideas
- Belgian Pharmaceuticals & Biotech Leverage Leaders
Belgian Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
Financière de Tubize
Market Cap: €8.6b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€189.40
7D
2.5%
1Y
16.6%
argenx
Market Cap: €56.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€897.60
7D
2.3%
1Y
47.7%
UCB
Market Cap: €42.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€221.00
7D
1.5%
1Y
9.8%